| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
138,010 |
128,098 |
$17.65M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
46,486 |
44,387 |
$5.99M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
41,945 |
40,876 |
$5.21M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28,439 |
26,331 |
$3.76M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17,405 |
17,194 |
$2.28M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,424 |
7,211 |
$916K |
| 99215 |
Prolong outpt/office vis |
844 |
815 |
$98K |
| 99201 |
|
300 |
300 |
$43K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
92 |
91 |
$13K |
| 99205 |
Prolong outpt/office vis |
53 |
53 |
$6K |
| 10060 |
|
16 |
16 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
559 |
484 |
$2K |
| 0011A |
|
91 |
90 |
$965.58 |
| 0012A |
|
36 |
35 |
$823.31 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,538 |
1,458 |
$793.75 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
669 |
338 |
$783.45 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,031 |
912 |
$638.92 |
| S9083 |
Global fee urgent care centers |
835 |
717 |
$132.50 |
| 81003 |
|
1,344 |
1,301 |
$103.00 |
| 93000 |
|
184 |
184 |
$0.00 |
| 91301 |
|
64 |
62 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
117 |
114 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
292 |
287 |
$0.00 |
| Q4049 |
Finger splint, static |
41 |
41 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
98 |
98 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
80 |
79 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
119 |
118 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
15 |
$0.00 |
| 73562 |
|
80 |
80 |
$0.00 |
| 82947 |
|
75 |
73 |
$0.00 |
| 73080 |
|
12 |
12 |
$0.00 |
| 73610 |
|
141 |
141 |
$0.00 |
| 73110 |
|
78 |
78 |
$0.00 |
| 73140 |
|
24 |
24 |
$0.00 |
| 73130 |
|
99 |
99 |
$0.00 |
| 73030 |
|
30 |
30 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
119 |
118 |
$0.00 |
| 90714 |
|
79 |
79 |
$0.00 |
| 81025 |
|
453 |
448 |
$0.00 |
| 73630 |
|
162 |
160 |
$0.00 |